NEXGEL, Inc. (NXGL) Revenue History
Annual and quarterly revenue from 2016 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
NXGL Revenue Growth
Revenue Breakdown (FY 2024)
NXGL's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
NXGL Revenue Analysis (2016–2024)
As of May 8, 2026, NEXGEL, Inc. (NXGL) generated trailing twelve-month (TTM) revenue of $11.7 million, reflecting slight decline in growth of -0.2% year-over-year. The most recent quarter (Q3 2025) recorded $2.9 million in revenue, up 1.7% sequentially.
Looking at the longer-term picture, NXGL's 5-year compound annual growth rate (CAGR) stands at +64.7%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $8.7 million in 2024, representing a new all-time high.
Revenue diversification analysis shows NXGL's business is primarily driven by Contract Manufacturing (89%), and Other Incomes (11%). With over half of revenue concentrated in Contract Manufacturing, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including LIQT (+11.0% YoY), XTLB, and BFRI (+11.8% YoY), NXGL has underperformed the peer group in terms of revenue growth. Compare NXGL vs LIQT →
NXGL Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| NXGLCurrent | $12M | -0.2% | +64.7% | -40.9% | |
 LIQT | $17M | +11.0% | -6.0% | -50.3% | |
 XTLB | $451,000 | - | - | -481.6% | |
 BFRI | $42M | +11.8% | +17.2% | -27.2% | |
 SKIN | $301M | -8.2% | +20.4% | -6.9% | |
 DERM | $56M | -27.4% | +10.0% | -24.4% |
NXGL Historical Revenue Data (2016–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $8.7M | +112.5% | $2.7M | 31.6% | $-3,554,000 | -40.9% |
| 2023 | $4.1M | +99.7% | $374K | 9.1% | $-3,477,000 | -85.0% |
| 2022 | $2.0M | +32.0% | $256K | 12.5% | $-3,348,000 | -163.5% |
| 2021 | $1.6M | +130.1% | $8K | 0.5% | $-2,570,000 | -165.7% |
| 2020 | $674K | -6.0% | $-291,000 | -43.2% | $-2,260,000 | -335.3% |
| 2019 | $717K | -67.6% | $-137,000 | -19.1% | $-1,924,000 | -268.3% |
| 2018 | $2.2M | +11.1% | $514K | 23.2% | $-1,888,000 | -85.3% |
| 2017 | $2.0M | -7.4% | $147K | 7.4% | $-969,000 | -48.6% |
| 2016 | $2.2M | - | $-114,000 | -5.3% | $-1,864,000 | -86.6% |
See NXGL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NXGL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NXGL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNXGL — Frequently Asked Questions
Quick answers to the most common questions about buying NXGL stock.
Is NXGL's revenue growth accelerating or slowing?
NXGL revenue growth slowed to -0.2%, below the 5-year CAGR of +64.7%. TTM revenue is $12M. The deceleration marks a shift from historical growth rates.
What is NXGL's long-term revenue growth rate?
NEXGEL, Inc.'s 5-year revenue CAGR of +64.7% reflects the variable expansion pattern. Current YoY growth of -0.2% is near this long-term average.
How is NXGL's revenue distributed by segment?
NXGL reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2016-2024 are available for download. Segment mix reveals concentration and diversification trends.